Novalung merged into Xenios AG

Novalung GmbH was absorbed into Xenios AG on August 30, 2019, streamlining processes and aligning more closely with parent company Fresenius Medical Care. The merger was notarized and entered in the commercial register in mid-August.

“Novalung GmbH, which specialises in solutions for respiratory failure, was absorbed into Xenios AG on 30 August 2019.”xenios-ag.com

• 1 source
• xenios-ag.comMerger: Novalung becomes fully integrated within Xenios - Xenios AGs.hubatschekSep 2, 2019

Summarized from public sources; check the original articles before acting on it.